These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 21599611

  • 1. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP.
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [Abstract] [Full Text] [Related]

  • 2. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus.
    Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, Koh YY, Chang KS, Hong SP.
    Platelets; 2013; 24(5):401-6. PubMed ID: 22871068
    [Abstract] [Full Text] [Related]

  • 3. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, Taguchi Y, Dougu N, Nozawa T, Tanaka K, Inoue H.
    Am J Cardiol; 2011 Mar 15; 107(6):912-6. PubMed ID: 21247518
    [Abstract] [Full Text] [Related]

  • 4. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.
    J Hypertens; 2006 Aug 15; 24(8):1531-9. PubMed ID: 16877955
    [Abstract] [Full Text] [Related]

  • 5. Stroke prevention in patients with non-valvular atrial fibrillation: new insight in selection of rhythm or rate control therapy and impact of mean platelet volume.
    Hong SP, Choi DH, Kim HW, Kim BB, Chung JW, Koh YY, Chang KS.
    Curr Pharm Des; 2013 Aug 15; 19(32):5824-9. PubMed ID: 23713815
    [Abstract] [Full Text] [Related]

  • 6. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):319-26. PubMed ID: 22319004
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V, Jurkovicová O, Kaluzay J, Stecová A, Pont'uch P.
    Vnitr Lek; 2010 Aug 15; 56(8):788-94. PubMed ID: 20845610
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 15; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 15; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 11. Outcome of atrial fibrillation among patients with end-stage renal disease.
    Chou CY, Kuo HL, Wang SM, Liu JH, Lin HH, Liu YL, Huang CC.
    Nephrol Dial Transplant; 2010 Apr 15; 25(4):1225-30. PubMed ID: 19923144
    [Abstract] [Full Text] [Related]

  • 12. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction.
    Tekbas E, Kara AF, Ariturk Z, Cil H, Islamoglu Y, Elbey MA, Soydinc S, Ulgen MS.
    Scand J Clin Lab Invest; 2011 Nov 15; 71(7):613-9. PubMed ID: 21859357
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
    Saad EB, d'Avila A, Costa IP, Aryana A, Slater C, Costa RE, Inácio LA, Maldonado P, Neto DM, Camiletti A, Camanho LE, Polanczyk CA.
    Circ Arrhythm Electrophysiol; 2011 Oct 15; 4(5):615-21. PubMed ID: 21841192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.
    Circulation; 2005 Jul 05; 112(1):110-6. PubMed ID: 15983245
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F.
    Stroke; 2014 Mar 05; 45(3):696-701. PubMed ID: 24519407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.